Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation

MLA

Tae-gyu Nam, et al. “Amelioration of Experimental Autoimmune Encephalomyelitis and DSS Induced Colitis by NTG-A-009 through the Inhibition of Th1 and Th17 Cells Differentiation.” Scientific Reports, vol. 8, May 2018. EBSCOhost, https://doi.org/10.1038/s41598-018-26088-y.

APA

Tae-gyu Nam, Sabita Neupane, Byeong-Seon Jeong, Maheshwor Timilshina, Sang Won Park, Jae-Hoon Chang, Sang Yeul Lee, Liyuan Jiang, Suman Acharya, Dong-Young Choi, & Jung-Ae Kim. (2018). Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation. Scientific Reports, 8. https://doi.org/10.1038/s41598-018-26088-y

Chicago

Tae-gyu Nam, Sabita Neupane, Byeong-Seon Jeong, Maheshwor Timilshina, Sang Won Park, Jae-Hoon Chang, Sang Yeul Lee, et al. 2018. “Amelioration of Experimental Autoimmune Encephalomyelitis and DSS Induced Colitis by NTG-A-009 through the Inhibition of Th1 and Th17 Cells Differentiation.” Scientific Reports 8 (May). doi:10.1038/s41598-018-26088-y.